Vertex (VRTX) PT Raised to $220 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Vertex (VRTX) PT Raised to $234 at BMO Capital
February 6, 2019 7:53 AM ESTBMO Capital analyst Do Kim raised the price target on Vertex (NASDAQ: VRTX) to $234.00 (from $192.00) while maintaining a Outperform rating.
Kim commented, "Our target price rises to $234 from $192, as we increase long-term CF revenue projections, following another solid 4Q18 beat on revenues and... More
Maxim Group Downgrades Vertex (VRTX) to Hold
February 6, 2019 7:45 AM ESTMaxim Group analyst Jason McCarthy downgraded Vertex (NASDAQ: VRTX) from Buy to Hold.
The analyst highlighted:
Vertex reported 4Q18 with cystic fibrosis (CF) revenue of $868M, representing sequential growth of 11% and beating consensus of $816M; the results include Kalydeco revenue of $259M vs. $250.5M... MoreVertex (VRTX) PT Lowered to $213 at RBC Capital
February 6, 2019 7:14 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on Vertex (NASDAQ: VRTX) to $213.00 (from $215.00) while maintaining a Outperform rating.
... MoreVertex (VRTX) PT Raised to $200 at UBS
February 6, 2019 6:32 AM ESTUBS raised its price target on Vertex (NASDAQ: VRTX) to $200.00 (from $188.00) while maintaining a Neutral rating.
... MoreVertex (VRTX) PT Raised to $216 at JMP Securities
February 6, 2019 4:13 AM ESTJMP Securities raised its price target on Vertex (NASDAQ: VRTX) to $216.00 (from $211.00) while maintaining a Market Outperform rating.
... MoreVertex (VRTX) PT Raised to $218 at Piper Jaffray
February 6, 2019 1:57 AM ESTPiper Jaffray analyst Edward Tenthoff raised the price target on Vertex (NASDAQ: VRTX) to $218.00 (from $217.00) while maintaining a Overweight rating.
... MoreVertex Pharma (VRTX) Tops Q4 EPS by 24c, Revenues Beat; Offers FY19 Revenue Guidance
February 5, 2019 4:03 PM ESTVertex Pharma (NASDAQ: VRTX) reported Q4 EPS of $1.30, $0.24 better than the analyst estimate of $1.06. Revenue for the quarter came in at $868 million versus the consensus estimate of $819.12 million.
"Our achievements in 2018 were marked by a significant increase in the number of CF... More
